1.25%
2.72%
-6.01%
-10.68%
-18.62%
-16.42%
49.43%
AI Spotlight on IDXX
Company Description
IDEXX Laboratories, Inc.develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide.The company operates through CAG; Water Quality Products; LPD; and Other segments.
It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community.The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits.In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E.
coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups.The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers.IDEXX Laboratories, Inc.
was incorporated in 1983 and is headquartered in Westbrook, Maine.
Market Data
| Last Price | 423.99 |
| Change Percentage | 1.25% |
| Open | 424.29 |
| Previous Close | 418.75 |
| Market Cap ( Millions) | 34718 |
| Volume | 507634 |
| Year High | 583.39 |
| Year Low | 398.5 |
| M A 50 | 423.89 |
| M A 200 | 468.83 |
Financial Ratios
| FCF Yield | 2.28% |
| Dividend Yield | 0.00% |
| ROE | 55.42% |
| Debt / Equity | 61.70% |
| Net Debt / EBIDTA | 54.99% |
| Price To Book | 21.57 |
| Price Earnings Ratio | 40.28 |
| Price To FCF | 43.8 |
| Price To sales | 9.03 |
| EV / EBITDA | 28.23 |
News
- Jan -27 - IDXX Gears Up for Q4 Earnings: What to Expect From the Stock?
- Jan -24 - IDXX Stock Set to Benefit From IDEXX Cancer Dx Diagnostic Panel Launch
- Jan -16 - IDEXX Laboratories to Release 2024 Fourth Quarter and Full Year Financial Results
- Jan -15 - IDEXX Stock Suffers Due to Macroeconomic Issues and FX Woes
- Dec -19 - SR Inc Announces 2024 SBER Awards: Top Honors Go to Synopsys, Nell Triplett of Juniper Networks, and IDEXX
- Dec -13 - A Once-in-a-Decade Opportunity: 2 Magnificent S&P 500 Stocks Down 37% and 28% to Buy Before 2025
- Dec -11 - Global Expansion to Support IDEXX Stock Despite Macroeconomic Issues
- Dec -09 - IDEXX Laboratories Announces Increase in Share Repurchase Program Authorization
- Nov -22 - Should You Hold IDEXX Stock in Your Portfolio for Now?
- Nov -21 - IDEXX Announces CFO Transition
- Nov -11 - IDEXX Laboratories Q3: Weak End-Market Demand Continues
- Nov -06 - Is It Time to Buy October's Worst-Performing Nasdaq Stocks?
- Nov -05 - A Once-in-a-Decade Opportunity: 1 Super S&P 500 Stock Down 40% to Buy After Its Recent Pullback
- Oct -31 - IDEXX Laboratories, Inc. (IDXX) Q3 2024 Earnings Call Transcript
- Oct -31 - CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results
- Oct -31 - Idexx Laboratories Adjusts Guidance As Q3 Revenue Growth Slows, Analyst Notes Fewer Veterinary Visits, Looks Towards Long-Term Growth
- Oct -31 - IDXX Q3 Earnings Top, '24 Sales View Down, Stock Dips in Premarket
- Oct -31 - Idexx (IDXX) Reports Q3 Earnings: What Key Metrics Have to Say
- Oct -31 - Idexx Laboratories (IDXX) Q3 Earnings Surpass Estimates
- Oct -31 - IDEXX laboratories cuts annual revenue forecast for third time as pet clinic visits slow
Business Breakdown
Expected Mid-Term Growth
Segment n°1 -> Companion Animal Group
Expected Growth : 8 %
What the company do ?
The Companion Animal Group from IDEXX Laboratories, Inc. provides diagnostic and software solutions for veterinarians to improve pet care and health outcomes.
Why we expect these perspectives ?
IDEXX Laboratories' Companion Animal Group growth is driven by increasing pet ownership, humanization of pets, and rising veterinary care spending. Additionally, advancements in diagnostic technology, expansion into emerging markets, and strategic acquisitions contribute to the 8% growth rate.
Segment n°2 -> Water
Expected Growth : 7 %
What the company do ?
Water from IDEXX Laboratories, Inc. provides water quality testing and monitoring solutions to ensure safe and clean water for human consumption, recreation, and environmental sustainability.
Why we expect these perspectives ?
IDEXX Laboratories' Water segment growth is driven by increasing global demand for water quality testing, stringent regulations, and rising concerns over waterborne diseases. The company's innovative products, such as Quanti-Tray and Colilert, are well-positioned to capitalize on this trend, with a 7% growth rate.
Segment n°3 -> Livestock, Poultry and Dairy
Expected Growth : 9 %
What the company do ?
Livestock, Poultry and Dairy from IDEXX Laboratories, Inc. provides diagnostic solutions for animal health, including tests for diseases and infections in livestock, poultry, and dairy animals.
Why we expect these perspectives ?
IDEXX Laboratories, Inc.'s 9% growth in Livestock, Poultry, and Dairy is driven by increasing demand for animal health diagnostics, rising adoption of digital technologies, and growing concerns over animal welfare and disease outbreaks. Additionally, the company's innovative products and services, such as diagnostic tests and software, are contributing to the segment's growth.
Segment n°4 -> Other
Expected Growth : 8 %
What the company do ?
The 'Other' segment from IDEXX Laboratories, Inc. includes products and services not classified under Companion Animal Group, Water, or Livestock, Pet and Poultry Diagnostics.
Why we expect these perspectives ?
IDEXX Laboratories, Inc.'s 8% growth in 'Other' segment is driven by increasing demand for pet insurance, expansion of veterinary consulting services, and growth in diagnostic testing for livestock and poultry. Additionally, the company's strategic acquisitions and investments in digital platforms have enhanced its offerings, contributing to the segment's growth.
Idexx Laboratories, Inc. Products
| Product Range | What is it ? |
|---|---|
| Companion Animal Group (CAG) Diagnostics | Diagnostic tests and instruments for veterinarians to diagnose and monitor diseases in companion animals |
| Livestock, Poultry and Dairy (LPD) Diagnostics | Diagnostic tests and instruments for livestock, poultry, and dairy farmers to diagnose and monitor diseases in their animals |
| Water Diagnostics | Diagnostic tests and instruments for water quality testing to detect bacteria, viruses, and other contaminants |
| Food Safety Diagnostics | Diagnostic tests and instruments for food manufacturers to detect pathogens and contaminants in food products |
| Rapid Assay Platforms | Portable, rapid diagnostic testing platforms for veterinary and food safety applications |
| Software and Services | Practice management software, data analytics, and consulting services for veterinary clinics and animal health organizations |
IDEXX Laboratories, Inc.'s Porter Forces
Threat Of Substitutes
IDEXX Laboratories, Inc. has a low threat of substitutes due to its strong brand recognition and patented products, making it difficult for new entrants to replicate its offerings.
Bargaining Power Of Customers
IDEXX Laboratories, Inc. has a medium bargaining power of customers due to the presence of large animal health companies and veterinary clinics, which can negotiate prices and terms.
Bargaining Power Of Suppliers
IDEXX Laboratories, Inc. has a low bargaining power of suppliers due to its strong relationships with suppliers and its ability to negotiate prices and terms.
Threat Of New Entrants
IDEXX Laboratories, Inc. has a low threat of new entrants due to the high barriers to entry, including regulatory hurdles and significant capital investments required to develop and commercialize veterinary diagnostic products.
Intensity Of Rivalry
IDEXX Laboratories, Inc. operates in a highly competitive industry with several established players, leading to a high intensity of rivalry among competitors.
Capital Structure
| Value | |
|---|---|
| Debt Weight | 38.97% |
| Debt Cost | 3.95% |
| Equity Weight | 61.03% |
| Equity Cost | 10.31% |
| WACC | 7.83% |
| Leverage | 63.85% |
IDEXX Laboratories, Inc. : Quality Control
IDEXX Laboratories, Inc. passed 7 out of 9 key points:
Historical Valuation
Price/Earnings Ratio
Margin Valuation
Peers Valuation
Competitors
| Company | Rational |
|---|---|
| IQV | IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: … |
| MTD | Mettler-Toledo International Inc. engages in the manufacture and supply of precision instruments and services worldwide. It operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and … |
| A | Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; … |
| TMO | Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences … |
| DHR | Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The … |
Peers Metrics
DCF BETA
Expected Cash-Flows
Scoring Insights
Peers Group Analysis
🥇
Mettler-Toledo
A-Score
1-Year Total Return ->
🥈
Thermo Fisher
A-Score
1-Year Total Return ->
🥉
Danaher
A-Score
1-Year Total Return ->
4
Agilent Technologies
A-Score
1-Year Total Return ->
5
IQVIA
A-Score
1-Year Total Return ->
6
